β-Lactams against Tuberculosis - New Trick for an Old Dog?

被引：98

作者：

Diacon, Andreas H. ^{[1
]}

van der Merwe, Lize ^{[2
]}

Barros-Aguirre, David ^{[3
]}

机构：

[1] Univ Stellenbosch, Cape Town, South Africa

[2] Task Appl Sci, Cape Town, South Africa

[3] GlaxoSmithKline, Madrid, Spain

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2016年 / 375卷 / 04期

关键词：

D O I：

10.1056/NEJMc1513236

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：393 / 394

页数：2

共 5 条

[1] Activity of amoxicillin/clavulanate in patients with tuberculosis [J].

Chambers, HF ;

Kocagöz, T ;

Sipit, T ;

Turner, J ;

Hopewell, PC .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :874-877

[2]

Donald PR, 2001, SCAND J INFECT DIS, V33, P466, DOI 10.1080/00365540152029954

[3] Meropenem-Clavulanate Is Effective Against Extensively Drug-Resistant Mycobacterium tuberculosis [J].

Hugonnet, Jean-Emmanuel ;

Tremblay, Lee W. ;

Boshoff, Helena I. ;

Barry, Clifton E., III ;

Blanchard, John S. .

SCIENCE, 2009, 323 (5918) :1215-1218

[4] Natural History of Tuberculosis: Duration and Fatality of Untreated Pulmonary Tuberculosis in HIV Negative Patients: A Systematic Review [J].

Tiemersma, Edine W. ;

van der Werf, Marieke J. ;

Borgdorff, Martien W. ;

Williams, Brian G. ;

Nagelkerke, Nico J. D. .

PLOS ONE, 2011, 6 (04)

[5]

World Health Organisation, 2013, GLOB TUB REP 2013

← 1 →